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Synopsis Reduced reproduction extends lifespan of females in many animals. To test the effects of reproduction on
storage of macronutrients, we block reproductive output in the lubber grasshopper by injecting RNAi against the pre-
cursor to egg-yolk protein, vitellogenin, in early adulthood. Controls were injected with either buffer or RNAi against the
major storage protein in the hemolymph, hexamerin-90. Vitellogenin RNAi greatly reduced both levels of mRNA for
vitellogenin and ovarian growth, in comparison to both controls. Fat body mass was increased upon vitellogenin RNAi,
but concentrations of the three hexameric storage proteins from the hemolymph were not. Surprisingly, hemolymph
vitellogenin levels were increased upon vitellogenin RNAi. Total reproductive protein (hemolymph vitellogenin plus
ovarian vitellin) was unchanged by vitellogenin RNAi, as reproductive protein was diverted to the hemolymph.
Similarly, the increased lipid storage upon vitellogenin RNAi was largely attributable to the reduction in lipid in the
ovary, due to decreased ovarian growth. A BLAST search revealed that the 515 bp sequence of vitellogenin used for RNAi
had three 11 bp regions identical to the vitellogenin receptor of the cockroach Leucophaea maderae. This suggests that our
treatment, in addition to reducing levels of vitellogenin transcript, may have also blocked transport of vitellogenin from
the hemolymph to the ovary. This would be consistent with halted ovarian growth simultaneous with high levels of
vitellogenin in the hemolymph. Nonetheless, the accumulation of vitellogenin, instead of hexameric storage proteins, is
inconsistent with a simple model of the trade-off between reproduction and storage. This was observed in young females;
future studies will address whether investment of proteins may shift to the soma as individuals age. Overall, our results
suggest that blockage of reproduction in young grasshoppers redirects lipids to storage and reproductive proteins to the
hemolymph.
Introduction
Life-history trade-offs between reproduction and lon-
gevity are well conserved (Flatt 2011). In particular,
many animals with reduced reproduction also exhibit
increased longevity and increased storage of lipids
(Hansen et al. 2013). For example, decreased repro-
duction, increased lifespan, and increased storage are
seen in nematodes upon ablation of the germ-line
cells (Goudeau et al. 2011), fruit flies lacking full
signaling for insulin-like peptides (Tatar et al.
2001), and mice lacking the receptor for growth hor-
mone (Masternak et al. 2012). Hence, the broader
trade-off between reproduction and longevity also
apparently involves a trade-off between reproduction
and storage. At the physiological level, individuals
that are long-lived tend to divert investment of
nutritional resources away from reproduction and
toward somatic storage (e.g., Glazier 1999). Here,
we examine the differential investment of mac-
ronutrients between reproduction and storage after
experimental reduction of reproduction via RNAi
knockdown.
Measurement of reproductive investment and
storage in an individual is a robust approach for
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analyzing physiological trade-offs. Our group has
spent more than a decade studying the physiology
of plasticity in reproductive timing and allocation
in the Eastern lubber grasshopper, Romalea micro-
ptera (Hatle et al. 2003a). These large insects lay
clutches of 30–60 eggs each (0.5–1.0 dry g) several
times during their lifetime. For the first clutch, adult
females that are fully fed become vitellogenic at
approximately 10 days. Upon synthesis by the fat
body, vitellogenin is released into the hemolymph,
reaching maximum levels between 20 and 25 days
(Hatle et al. 2001). Concurrent high levels of juvenile
hormone (JH) stimulate transcription of vitellogenin
by the fat body and likely trigger uptake of circulat-
ing vitellogenin into the growing oocytes of the ovary
(Borst et al. 2000; Fei et al. 2005). Slight modifica-
tion of vitellogenin upon uptake into the oocytes
yields vitellin granules, which constitute approxi-
mately 90% of the total protein found within the
oocytes. Oviposition then occurs around 35–
40 days (Hatle et al. 2001; Drewry et al. 2011).
The effects of reproduction on lifespan are also
well studied in lubber grasshoppers. Ovariectomy in
adult females increases lifespan by approximately
20% (Drewry et al. 2011). In older adults, ovariec-
tomy also augments somatic storage, as fat body
mass, hemolymph volume, and levels of hexameric
storage proteins in the hemolymph (see below) are
all doubled after approximately 75 days (Hatle et al.
2008, 2013; Judd et al. 2011). At the same time,
ovariectomy does not block the production of vitel-
logenin by the fat body, but it cannot be sequestered
into the ovary, so vitellogenin accumulates in the
hemolymph (Hatle et al. 2003b).
Hexameric storage proteins often are used to sup-
port key life-history events in insects, such as molt-
ing and reproduction (Telfer and Kunkel 1991;
Burmester 1999). The hexamerins are degraded
during these vital events and the amino acids are
used for multiple purposes. In lubber grasshoppers,
three major hexamerins are synthesized by the fat
body and secreted into the hemolymph. They are
named based on their sizes of 90, 270, and 500 kDa
when separated on native-gel electrophoresis. The
90 kDa storage protein (hexamerin-90) is classified
as an arylphorin because it is rich in aromatic
amino acids. It is the most abundant of the three
hexamerins, constituting approximately 70%
of the total storage protein. The maximum titer of
hexamerin-90 is attained at approximately 20 days
after adult molt, in the middle of the female’s ovipo-
sition cycle (Hathaway et al. 2009). The importance
of the three hexamerins in reproduction is illustrated
by the fact that their collective maximum titer was a
strong predictor (even better than vitellogenin) of
the number of eggs produced in a clutch (Hatle
et al. 2001).
Here, we use RNAi post-transcriptional silencing
of vitellogenin to address the physiological mecha-
nisms underlying the trade-off between reproduction
and storage. Vitellogenin has a conserved, central
role in reproduction, and also in aging (Brandt
et al. 2005). Despite this, to our knowledge, knock-
down of vitellogenin has been used only in nematode
worms once (Murphy et al. 2003) and in honey bees’
social organization extensively (Amdam 2010). The
role of vitellogenin in worker bees is very different
from the role of vitellogenin in non-social insects.
Worker bees are non-reproductive females dedicated
first to nursing in the colony and then to foraging
for the colony. Treatment of worker nurse bees with
RNAi against vitellogenin results in accelerated pro-
gression to foraging, and decreased stress resistance,
survival, and storage of nutrients. Hence, vitellogenin
affects storage and survival in worker bees, but in the
opposite direction to which reproduction affects
storage and survival in other animals (Amdam
2010; Hansen et al. 2013).
Based on previous observations on various model
organisms (see Hansen et al. 2013) as well as ovari-
ectomized lubber grasshoppers, we hypothesize that
reduction of reproductive output through direct
knockdown of vitellogenin mRNA will lead to an
increase in somatic storage, which could have possi-
ble life-extending implications. In particular, we pre-
dict that RNAi of vitellogenin will halt ovarian
growth, and as a result, lipids will be invested




Eastern Lubber grasshoppers were obtained as juve-
niles from the Ortega Farms population in
Jacksonville, FL, USA, to test physiological effects
of vitellogenin RNAi on reproduction and storage
(Experiments 1 and 3) or from a colony maintained
at Illinois State University to test effects of vitello-
genin RNAi on clutch parameters (Experiment 2).
Juveniles were reared communally on an ad libitum
diet of Romaine lettuce daily and oatmeal occasion-
ally. Upon molting into adulthood, virgin females
were raised individually on lettuce only (Drewry
et al. 2011). They were serially assigned into three
treatment groups: RNAi treatment for vitellogenin
(Vg RNAi), RNAi treatment for the 90 kDa hexame-
ric storage protein (Hex-90 RNAi) as control for
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RNAi effects on physiology, or buffer-injected con-
trol. Knockdown of Hex-90 was used as a control
instead of a ‘‘scramble’’ dsRNA control because
actually knocking down a transcript in the animal
more closely simulates any off-target effects stimu-
lated by a generalized ‘‘RNAi response’’.
dsRNA synthesis and injection
The dsRNA for injections was made according to
Ambion’s MEGAscript RNAi Kit (Life Technologies,
Grand Island, NY, USA). First, total RNA was
extracted from fat body tissue of vitellogenic females
(RiboPureTM Kit, Ambion, Life Technologies), then
reverse transcribed to cDNA (iScriptTM cDNA Synth-
esis Kit, Bio-Rad Laboratories, Hercules, CA, USA),
and used to construct a DNA template for dsRNA
synthesis.
To construct DNA templates, sequence-specific pri-
mers (see Table 1 for primers; see Supplementary
Tables S1–S3 for the regions of the genes that were
amplified) for vitellogenin and hexamerin-90 were
designed using Primer3 software to select products of
approximately 500 bp. The following quantitative
polymerase chain reaction (qPCR) thermocycling
parameters were used: 45 cycles of 95/52/728C for
45/60/45 s, respectively. Products from identical PCR
reactions were sequenced by the Nevada Genomics
Center to confirm the correct amplicon was produced.
To convert the DNA to RNA, the transcription reac-
tions followed the manufacturer’s protocols except the
reactions ran for 4 h with 8 mL of the qPCR product as
template (rather than 1 mg as specified by the manu-
facturer’s protocol).
For R. microptera vitellogenin, only 733 bp of the
sequence are known. The 661 bp dsRNA against
vitellogenin shares 98% identity with the 515 bp
dsRNA (see Supplementary Table S1). Hence, the
second set of primers serves as a second test that
the product produced is from vitellogenin, but due
to sequence overlap it does not check for possible
annealing to other transcripts in the animal that
may lead to non-target effects of RNAi.
Aliquots (5mg in variable volumes) of dsRNA were
stored at 208C and brought up to 30 mL using
nuclease-free water or injection buffer (10 mM Tris–
HCl and 1 mM ethylenediaminetetraacetic acid) just
prior to injection. At day 5, animals were injected
with the dsRNA of respective treatments intra-
abdominally between the fifth and sixth sterna.
Experiment 1: physiological effects of vitellogenin
RNAi on reproduction and storage
Design
Upon molting into adulthood, virgin females were
serially assigned to one of three treatment groups
(Vg RNAi, Hex-90 RNAi, or Buffer). Within these
groups, animals were dissected at ages 12, 19, 26, and
33 days (1 day), with each age group containing
seven to nine individuals.
Collection of data
At the time of dissection, hemolymph samples of
5 mL were collected and diluted into 250 mL of phos-
phate-buffered saline for quantification of vitello-
genin and hexamerin protein levels (Hatle et al.
2008; Hathaway et al. 2009). Fat body tissues and
ovaries were harvested and their wet masses were
recorded (Hatle et al. 2005). Approximately 50 mg
of fat body tissue was stored in RNAlater
Solution (Ambion, Life Technologies) at 208C.
mRNA quantification
Total RNA was extracted from fat body tissue, stored
in RNAlater, and then converted to cDNA (as de-
scribed above). Transcript abundance for vitellogenin
and hexamerin-90 in the fat body was quantified (rel-
ative to b-actin) utilizing qPCR. The composition of
the reactions was 10 mL of iQTM SYBR Green
Supermix (Bio-Rad Laboratories), 1 mL (10 mM) each
of sequence-specific forward and reverse primers, 1 mL
Table 1 Primers used for PCR to produce templates for production of dsRNAs for RNAi
Primer name Primer sequence
Vitellogenin forward (515 bp) 50-TAATACGACTCACTATAGGGAGAAGACCCAACTTCGCGATATG-30
Vitellogenin reverse (515 bp) 50-TAATACGACTCACTATAGGGAGAAGCGCTGGAAAGAGGATACA-30
Hexamerin-90 forward 50-TAATACGACTCACTATAGGGAGATACTATGGATCACTTTACAG-30
Hexamerin-90 reverse 50-TAATACGACTCACTATAGGGAGATTGTGGTTCATGCGGTACTGG-30
Vitellogenin forward (661 bp) 50-TAATACGACTCACTATAGGGAGAATCCAGAAATCAACGGCAAA-30
Vitellogenin reverse (661 bp) 50-TAATACGACTCACTATAGGGAGATGGAAGAGCTCCAGGAAGT-30
Notes: For vitellogenin primers, the numbers refer to the length in base pairs of the final product. Unless specified in the text, the vitellogenin
RNAi was accomplished with the primers for the 515 bp sequence. The first 23 base pairs of each primer, highlighted in gray, are identical and
represent the T7 polymerase promoter required for transcription.
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of cDNA, and 7 mL of nuclease-free water. The vitello-
genin primers were from Borst et al. (2000), the hex-
amerin-90 primers were from Hathaway et al. (2009),
and the b-actin primers were from Fei et al. (2005).
The qPCR parameters were 958C for 1 min followed by
30 cycles of 95/50/728C each for 30 s (MJ Mini-
opticon, Bio-Rad Laboratories).
Quantification of hexamerin
From the hemolymph samples, hexamerins were
quantified by native polyacrylamide gel electrophore-
sis. Samples were run on 4%!20% acrylamide-gra-
dient gels (Bio-Rad Laboratories) at 48C for 12 h
(Hathaway et al. 2009), and then stained with
Coomassie blue. Internal standards of bovine serum
albumin (0.005%, 0.05%, and 0.5%) were run on
each gel to establish a standard curve for the quan-
tification of protein. Gels were imaged (Kodak Gel
Logic 1500) and uploaded into ImageJ. The quantity
of protein for each sample was determined by com-
parison to the standards of bovine serum albumin;
this ImageJ analysis was conducted blind to the
experimental treatments.
Quantification of vitellogenin protein
Vitellogenin in the hemolymph was quantified by
enzyme-linked immunosorbent assay (ELISA) as in
previous work (Borst et al. 2000; Hatle et al. 2008).
Total reproductive protein was estimated from
ovarian mass and hemolymph vitellogenin. In
insects, the precursor to egg-yolk protein (viz.,
vitellogenin) is produced by the fat body, released
to the hemolymph, and later sequestered into the
ovary to become vitellin. Together, vitellin and vitel-
logenin make up the total reproductive protein of
the individual. To estimate the amount of vitellin
in each growing ovary, we started with the fact
that a typical, full first clutch is 55 eggs and weighs
about 4000 mg (Drewry et al. 2011). From this ratio,
we calculated the number of full-size egg equivalents
that would be contained in each ovary. The average
dry mass of an egg is 15 mg (Moehrlin and Juliano
1998), and each egg is approximately 50% protein,
90% of which is vitellin. Hence, the number of egg
equivalents was multiplied by 7 mg to estimate the
total amount of vitellin. To estimate the total
amount of vitellogenin, we used the estimate of he-
molymph volume of 2.25 mL (25% of the mass of
a gravid female) for buffer-injected and hexamerin-
90 RNAi animals. This estimate of hemolymph
volume was increased 25% for vitellogenin RNAi an-
imals, based on results of pilot experiments using
3H-inulin as a volume marker (J. D. Hatle, unpub-
lished data). The hemolymph volume was multiplied
by the concentration of vitellogenin (Fig. 2) to
obtain the estimate of total vitellogenin. Total repro-
ductive protein is the sum of vitellin and
vitellogenin.
Experiment 2: clutch parameters
To determine whether vitellogenin RNAi delayed
oviposition or reduced the size of clutches, grasshop-
pers were administered dsRNA within 2 days after
laying their first clutch. Injection treatments were the
same as in Experiment 1 (Vg RNAi, Hex-90 RNAi,
or Buffer) with an additional 661 bp dsRNA against
vitellogenin (see Table 1 and Supplementary Table
S1) and included 7–10 individuals per treatment.
The preparation and delivery of injections were per-
formed the same as in Experiment 1.
Grasshoppers were tested for oviposition three
times per week, on non-consecutive days. Upon
laying, age of the female was recorded, number of
eggs per clutch was counted, and the length of five
representative eggs was measured (Drewry et al.
2011).
Experiment 3: mass-specific, in vitro production
of vitellogenin
To determine whether vitellogenin continued to be
produced after administering vitellogenin RNAi,
we measured the rate of production of vitellogenin
in vitro at 19 and 26 days. These ages were selected
because this is about the period of peak production
of vitellogenin (Borst et al. 2000; Hatle et al. 2005).
Injection treatments were the same composition and
at the same developmental age as in Experiment 1.
Production of vitellogenin was measured accord-
ing to previously described methods (Fei et al. 2005;
Hatle et al. 2005). Briefly, small sheets of fat body
were incubated in 500 mL of modified Grace’s
medium for 2 h to rinse the tissue and release vitel-
logenin from damaged cells. This step was tested by
poisoning some test wells with sodium azide; the
rinse removes most but not all of the vitellogenin.
After the 2 h rinse, the fat body was transferred to
another well with identical Grace’s medium for 4 h
to measure the production of vitellogenin. At the end
of the 4 h incubation, the fat body was removed and
the medium was tested for vitellogenin by ELISA.
Statistics
All data were analyzed utilizing SAS statistical soft-
ware (SAS Institute Inc, Cary, NC, USA) using two-
way analyses of variance (ANOVAs) or multiple ana-
lyses of variance (MANOVAs) (injection and time as
independent variables).
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Results
To verify the knockdown of gene expression in
response to injections (applied at age 5 days), tran-
script levels both for vitellogenin and for hexamerin-
90 relative to b-actin were quantified at ages 12, 19,
26, and 33 days after adult molt (Fig. 1). The mRNA
levels were significantly affected by injections (two-
way MANOVA, Pillai’s Trace F4,78¼ 10.26,
P50.0001), age (F6,78¼ 2.56, P¼ 0.0258), and the
interaction of injection and age (F12,78¼ 1.98,
P¼ 0.0370). In particular, levels of vitellogenin
mRNA were reduced approximately 35-fold
(F2,48¼ 16.81, P50.0001) and hexamerin-90 mRNA
levels were reduced approximately four-fold
(F2,48¼ 7.83, P¼ 0.0054) upon their respective
RNAi treatments. Further, levels of vitellogenin
mRNA were affected by age (F3,47¼ 5.46,
P¼ 0.0031), with higher levels at 19 days than at
any other sampling point. In contrast, levels of hex-
amerin-90 mRNA were not affected by age
(F3,47¼ 0.45, P¼ 0.7163). The interaction of injec-
tion and age was significant for vitellogenin mRNA
(F6,44¼ 3.08, P¼ 0.0145), mostly because levels
remained low upon vitellogenin RNAi but peaked
at 19 days upon treatment with hexamerin-90
RNAi or buffer. The interaction was not significant
for hexamerin-90 mRNA (F6,44¼ 1.14, P¼ 0.3579).
Because they are two related indices of reproductive
proteins, ovarian mass and levels of hemolymph vitel-
logenin were analyzed by a single two-way MANOVA
(Fig. 2). Both indices were significantly affected by in-
jections (Pillai’s Trace F4,174¼ 28.39, P50.0001), age
(F6,174¼ 19.69, P50.0001), and the interaction of in-
jection and age (F12,174¼ 6.20, P50.0001). Ovarian
mass was very strongly affected by injection
(F2,96¼ 140.93, P50.0001), age (F3,95¼ 118.91,
P50.0001), and interaction (F6,92¼ 18.04,
P50.0001). As expected, ovarian mass was lower in
younger animals and in animals injected with vitello-
genin RNAi. Levels of hemolymph vitellogenin were
affected by injection (F2,96¼ 14.39, P50.0001), but
not by age (F3,95¼ 0.46, P¼ 0.7103) or interaction
(F6,92¼ 1.32, P¼ 0.2549). All main effects of injection
were due to vitellogenin RNAi, and not to hexamerin-























































Fig. 2 Wet ovarian masses and circulating vitellogenin levels
upon RNAi treatments were measured in lubber grasshoppers to
assess the effects on normal reproductive physiology. Ovarian
masses of grasshoppers treated with vitellogenin RNAi were
decreased significantly as of 19 days of age, compared with both
control groups. Circulating vitellogenin levels were, surprisingly,
increased in individuals treated with vitellogenin RNAi, likely due
to a lack of uptake into the developing ovaries. Letters above













































Fig. 1 The relative expression of vitellogenin and hexamerin-90
mRNA in comparison to a b-actin standard in lubber grasshop-
pers. Values are presented in molar concentrations due to dif-
fering base pair lengths of real-time PCR products. Letters above
error bars indicate significant differences within an age cohort.
The respective RNAi treatments significantly reduced both vi-
tellogenin and hexamerin-90 transcript abundance across all four
ages.
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To incorporate the relative contribution both of
ovarian growth and of vitellogenin levels in repro-
ductive investment, we estimated the total content
of reproductive protein for each individual. We
assumed that the largest ovarian masses (i.e.,
4000 wet mg), which had full size oocytes needing
only to be chorionated before oviposition, would
result in a large clutch of 55 eggs (see Drewry
et al. 2011). Hence, each gram of ovary was esti-
mated to contain 13.75 egg equivalents of vitellin.
As described in the ‘‘Materials and Methods’’ section,
previous studies have shown that each mature egg
contains approximately 7 dry mg of vitellin
(Moehrlin and Juliano 1998; Hatle et al. 2008), so
this was multiplied by the estimated number of egg
equivalents for each individual’s ovary to yield the
total vitellin for that grasshopper. Next, the concen-
tration of hemolymph was multiplied by the previ-
ously estimated hemolymph volume of 2.25 mL
(further increased by 25% for vitellogenin RNAi
individuals: see ‘‘Materials and Methods’’ section)
to yield the total amount of vitellogenin per individ-
ual. The final estimate of the total reproductive
protein was the sum of total vitellin and total vitel-
logenin for that individual. Two-way ANOVA
showed an overall effect (F11,98¼ 2.91, P¼ 0.0026).
Total reproductive protein rose with advancing age
(F3,95¼ 9.28, P50.0001), but remarkably was not
affected by injection (F2,96¼ 0.42, P¼ 0.6593) or
interaction (F6,92¼ 0.70, P¼ 0.6538).
The mass of the fat body is an index of storage,
and two-way ANOVA revealed an overall effect
(Fig. 3; F11,98¼ 13.10, P50.0001). Specifically, fat
body mass was strongly affected by injection
(F2,96¼ 52.02, P50.0001) with vitellogenin RNAi
increasing mass, affected slightly less by age
(F3,95¼ 3.74, P¼ 0.0140) with a peak at 19 days,
and affected by the interaction of injection and age
(F6,92¼ 5.62, P50.0001). In general, mass of the fat
body increased with age upon injection of vitello-
genin RNAi but did not change with age upon ad-
ministering Hex-90 RNAi or buffer.
The content of all three hexameric storage proteins
was analyzed in a single two-way MANOVA (Fig. 4).
There was no effect of injection (F6,160¼ 1.22,
P¼ 0.2988), a marginal effect of age (F9,243¼ 1.82,
P¼ 0.0644), and no effect of interaction
(F18,243¼ 0.70, P¼ 0.8125). Hexamerin-90 levels were
five-fold lower upon treatment with Hex-90 RNAi, but












































































Buffer Hex-90 RNAi Vg RNAi (515 bp)
Fig. 4 Hemolymph levels of three different hexameric storage
proteins during the first oviposition cycle in lubber grasshoppers,
upon RNAi injections. Hexamerin-90 protein levels were mar-
ginally reduced upon Hex-90 RNAi treatment (see text for de-
tails). Levels of hexamerin-270 and hexamerin-500 were affected




































Fig. 3 Average fat body masses measured at time of dissection in
response to three different injections in lubber grasshoppers.
Vitellogenin RNAi treatment doubled fat body mass, illustrating a
shift in somatic storage upon direct reduction of reproduction.
Letters above error bars indicate significant differences within an
age cohort.
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(F2,90¼ 2.57, P¼ 0.0825). To further probe the possi-
bility of the effects of RNAi on hexamerin-90 levels, we
combined the treatments of vitellogenin RNAi and
buffer and compared this combination against the
treatment with Hex-90 RNAi, using a one-way
ANOVA. This produced an overall effect
(F7,92¼ 2.20, P¼ 0.0418). The result was due only to
a significant effect of injection (F1,91¼ 5.20,
P¼ 0.0250), and not to age (F3,89¼ 1.14, P¼ 0.3378)
or interaction (F3,89¼ 0.86, P¼ 0.4644). Taken to-
gether, this suggests that Hex-90 RNAi often had a
large effect on the levels of hexamerin-90 protein, but
this was highly variable.
Hemolymph ecdysteroids were also quantified to
determine whether the ovary of individuals injected
with vitellogenin RNAi was functional as an endo-
crine organ. Previous work has shown that ecdyste-
roids are produced by the ovary and present only
during an approximately 4-day period about 2
weeks before oviposition (Hatle et al. 2003b).
Hence, only samples collected on days 19 and 26
were tested for ecdysteroids, and all samples were
tested independently because each individual had a
sample for only one of the two dates. Because the
samples were only collected every 7th day, it would
be expected that certain ecdysteroid peaks would be
missed, even for individuals producing the steroid.
Thus, we tested whether the treatment groups dif-
fered in the number of individuals in which ecdys-
teroids were detected, as well as comparing
ecdysteroid titers directly. There was no effect of in-
jection on ecdysteroid levels (one-way ANOVA,
F2,47¼ 0.88, P¼ 0.4235; Fig. 5), but this is not
surprising considering detection error. Of the 13 in-
dividuals injected with vitellogenin RNAi, three had
detectable ecdysteroids in each of two separate assays
(detection minimum mean SE¼ 32.8 3.4 pg/mL).
This ratio of detectable to injected was not signifi-
cantly different from either buffer-injected or Hex-90
RNAi-injected grasshoppers (2¼ 0.503, df¼ 1, crit-
ical value¼ 3.84).
To further explore our unexpected effects of vitel-
logenin knockdown, in Experiment 2 we tested a
second dsRNA against vitellogenin (viz 661 bp Vg
RNAi) on reproductive tactics. Test solutions were
injected after the first oviposition. There were mini-
mal effects on the second clutch, not surprising con-
sidering that nutrients allocated to the second clutch
are partly sequestered at the time of first oviposition.
However, analysis of effects on the third clutch re-
vealed a marginal reduction in number of eggs (one-
way MANOVA, F3,18¼ 3.14, P¼ 0.0566), a highly
significant reduction in the length of each egg
(Fig. 6; F3,18¼ 12.72, P¼ 0.0002), and a significant
increase in the duration from clutch 2 to clutch 3
(F3,18¼ 7.33, P¼ 0.0030). In particular, treatment
with 661 bp vitellogenin RNAi significantly reduced
the size of eggs in comparison both to buffer-injec-
tion (P¼ 0.0023) and to Hex-90 RNAi (P¼ 0.0038).
Further, treatment with 661 bp vitellogenin RNAi
significantly increased the duration of clutch 3
upon buffer-injection (P¼ 0.0275), but not upon in-
jection with Hex-90 RNAi (P¼ 0.1011). In contrast,
the 661 bp vitellogenin RNAi did not affect the
number of eggs produced. These results, in conjunc-
tion with the mRNA data, clearly support the con-
clusion that our RNAi treatments affect
reproduction.
Experiment 3 had the same design as Experiment
1 (i.e., injection of buffer, Hex-90 RNAi, and vitel-
logenin RNAi [515 bp]). We measured vitellogenin
synthesis in vitro at days 19 and 26. Our goal was











































Fig. 6 Mean egg size of the third clutch and clutch interval
(period between second and third clutch) in lubber grasshoppers
injected after first oviposition, upon RNAi injections. Overall, the
duration of the clutch interval was extended, and egg size was
significantly reduced in both Vg RNAi treatment groups. Letters
above error bars indicate significant differences within a repro-






























Buffer Hex-90 RNAi Vg RNAi (515 bp)
Fig. 5 Hemolymph ecdysteroid levels measured for either age 19
or 26 days were not significantly affected by injection treatments
in lubber grasshoppers. This suggests that ovarian endocrine
signaling is left intact following Vg RNAi treatment.
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produced at later ages, or if all the hemolymph vi-
tellogenin present was produced at younger ages.
Two-way ANOVA revealed only marginal overall ef-
fects (Fig. 7; F5,36¼ 2.21, P¼ 0.0781). However, these
were due entirely to age (F1,35¼ 6.20, P¼ 0.0183),
and not to injection (F2,34¼ 0.99, P¼ 0.3831) or in-
teraction (F2,34¼ 0.61, P¼ 0.5474). There was greater
production at 19 days than at 26 days across all
groups, as in previous experiments (Hatle et al.
2005).
Discussion
Overall, the results of this study illustrate a reduction
of reproduction through treatments with vitellogenin
RNAi that directly decrease vitellogenin mRNA but
do not decrease levels of vitellogenin protein. When
vitellogenin RNAi was injected prior to vitellogenesis,
ovarian growth was nearly halted. Injection during
the normal reproductive period (i.e., after first ovi-
position) reduced egg size and increased the interval
between clutches. Hence, in two independent exper-
iments, treatment with vitellogenin RNAi drastically
reduced reproductive output. These results are not
attributable to general effects of RNAi (e.g., Alic
et al. 2012), as a Hex-90 RNAi control altered nei-
ther vitellogenin mRNA levels nor reproductive
growth.
Our results imply that the treatment with vi-
tellogenin RNAi affects either transport of vitel-
logenin from the hemolymph into the ovary or
vitellogenin transcription itself. Treatment with vitel-
logenin RNAi resulted in animals with little vitellin
in the oocytes even though high levels of vitellogenin
were in the hemolymph. This phenotype resembles
German cockroaches with the vitellogenin receptor
knocked down by RNAi (Ciudad et al. 2006), silk-
worms with mutations in the vitellogenin receptor
(Lin et al. 2013), and Drosophila mutants with loss
of function in the receptor for yolk protein
(Schonbaum et al. 1995). There are some similarities
between the sequences for insect vitellogenins and
the sequences for insect vitellogenin receptors.
BLAST analysis revealed that our 515 bp dsRNA
against vitellogenin of lubber grasshoppers matched
three separate 11 bp segments of the mRNA coding
sequence for the vitellogenin receptor of the
cockroach Leucophaea maderae (Tufail and Takeda
2007). Although this is about half of the 22 bp
length of a typical siRNA, there may be some inhi-
bition of gene expression by segments as short as
8 bp (e.g., Jackson and Linsley 2010). Therefore, it
is possible that our RNAi constructs designed for
use against the vitellogenin gene for the lubber grass-
hopper may have also had activity against their
vitellogenin receptor. Unfortunately, we have not
yet cloned the vitellogenin receptor from lubber
grasshoppers to test this hypothesis. Regardless of
the activity of the vitellogenin receptor, the consid-
erable inhibition of reproductive development in our
experiments allows examination of the trade-off
between reproduction and storage (Glazier 1999).
Storage and allocation of protein
Although vitellogenin RNAi nearly stopped deposi-
tion of vitellin by reducing ovarian growth, it in-
creased vitellogenin levels in the hemolymph. When
we estimated the combination of both vitellogenin
circulating in the hemolymph and vitellin seques-
tered into eggs, our analysis suggested that levels of
total reproductive protein were not changed signifi-
cantly by vitellogenin RNAi. That is, treatment with
vitellogenin RNAi did not reduce investment in
reproductive protein, only whether the protein was
invested into the ovary or was kept circulating in the
hemolymph.
The reduction in levels of vitellogenin mRNA, but
maintenance of levels of total reproductive protein,
suggests there may be regulation at the level of trans-
lation or of ovarian uptake. It could be that the
production of vitellogenin continues, or perhaps
(but not mutually exclusively) all the vitellogenin
present in the hemolymph (Fig. 2) was produced
before the effect of the injections of vitellogenin
RNAi, and the vitellogenin was retained in the he-
molymph thereafter. To address this question, we
tested the in vitro, mass-specific production of vitel-
logenin at 19 and 26 days. Surprisingly, vitellogenin
RNAi did not change the in vitro rate of production
of vitellogenin in comparison to Hex-90 RNAi or to
buffer-injection. Even so, vitellogenin production was
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Fig. 7 In vitro production of vitellogenin by the fat body upon
three different injections in lubber grasshoppers. Production was
significantly higher at 19 days than on 26 days but was not af-
fected by injection.
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expected developmentally (e.g., Borst et al. 2000);
this supports the veracity of the dataset. In the con-
text of reduced levels of vitellogenin mRNA, sus-
tained production of vitellogenin by the fat body is
consistent with an increase in the rate of translation
relative to the number of vitellogenin transcripts pre-
sent. Indeed, production of vitellogenin by lubber
grasshoppers has been shown to be subject to trans-
lational regulation, as vitellogenin production plum-
mets after 4 days of starvation whereas levels of
vitellogenin mRNA remain unchanged (Fei et al.
2005). A final possibility is that vitellogenin is pro-
duced but then remains in the fat body. Although we
did not measure this, it would be inconsistent with
reduced levels of vitellogenin mRNA in concert with
maintained levels of total reproductive protein.
The locations of total reproductive proteins
change upon injection with vitellogenin RNAi,
whereas the amounts of total reproductive proteins
are altered little. The process that appears to be most
affected is the uptake of vitellogenin from the hemo-
lymph into the ovarian follicles. Patency is a two-step
process. First, the follicle cells of the ovaries shrink to
open conduits between the cells, thereby allowing
circulating vitellogenin to make contact with the
surface of the oocytes (Abu-Hakima and Davey
1977). Second, vitellogenin is taken up from the he-
molymph into the oocyte by receptor-mediated
endocytosis involving the vitellogenin receptor, a
member of the family of low-density lipoprotein re-
ceptors (Raikhel and Dhadialla 1992; Tufail and
Takeda 2009). Our results are consistent with block-
age of the second step, that is, preventing vitello-
genin from moving into the ovaries but instead
accumulating in the hemolymph.
Patency is regulated by JH (Chapman 1998). We
quantified JH levels from these animals, but there
was no detectable effect of vitellogenin RNAi on JH
levels (Supplementary Fig. S1). Previous work sug-
gests that tracking JH levels throughout the oviposi-
tion cycle of an individual is critical for identifying
changes, as absolute levels vary greatly from one in-
dividual to the next, but the typical pattern is highly
consistent across individuals (Hatle et al. 2000).
Hence, the lack of significant effect found here is
not surprising due to the sampling approach (i.e.,
only a single sample from each individual).
These results on protein redirection upon experi-
mental reduction of reproduction are somewhat
counter to a simple view of the model of the
trade-off between reproduction and longevity. A
straightforward view of the model would predict
that blocking reproduction would result in an in-
crease of hexameric storage proteins, as this is the
insect depot for amino acids. However, vitellogenin
RNAi did not affect levels of any of the three
hexamerins. Instead, we observed reproductive pro-
teins (in the form of vitellogenin) accumulating in
the hemolymph. Indeed, the difference in levels of
vitellogenin between the vitellogenin RNAi group
and the controls increased throughout the course
of the experiment, only becoming significant
(within an age group) at the final sampling date.
From the present data, there is no evidence of even
a trend toward increased somatic investment of pro-
teins. This experiment used young grasshoppers,
ending at 33 days, just prior to first oviposition. In
the laboratory, lubber grasshoppers can lay over 10
clutches and have a median lifespan of 245 days
(Drewry et al. 2011). It may be that this investment
in vitellogenin would shift to somatic proteins in
older grasshoppers, allowing and increase in lifespan.
Future experiments will examine the effect of vitel-
logenin RNAi on lifespan and protein investment in
older grasshoppers.
Storage and allocation of lipids
Knockdown of vitellogenin mRNA had large effects
on investment in Iipids. Mass of the fat body was
doubled upon treatment with vitellogenin RNAi,
consistent with a trade-off between reproduction
and storage. The fat body is the primary depot for
lipid and carbohydrate in insects (e.g., Chapman
1998), so our results imply that organismal storage
of both of these macronutrients was increased. Eggs,
and therefore mature oocytes, are about half protein
and half lipid (e.g., Chapman 1998). By halting ovar-
ian growth via vitellogenin RNAi, a major deposition
of lipid is blocked (cf. Fig. 3 and top panel of Fig. 2).
Unfortunately, we did not analyze the macronutrient
composition of fat bodies. However, calculations can
be used to estimate whether lipids were reduced or
diverted to a new location. At 33 days, the masses of
the fat bodies in individuals treated with vitellogenin
RNAi were about 250 wet mg greater than those of
controls. Estimates vary for conversions from wet
adipose mass to dry adipose mass, but a typical es-
timate seems to be that adipose consists of 40%
water (Baker 1969), and this is in good agreement
with comparisons of dry and wet fat body masses
across our past experiments with lubber grasshoppers
(cf. this article and Hatle et al. 2005). Hence, the
typical increase in fat body lipid of 250 wet mg con-
verts to about 150 dry mg of lipid. This suggests that,
upon treatment with vitellogenin RNAi, about 60%
of the lipid that would have accumulated in the
ovary is diverted to the fat body. This reduction in
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investment of lipid to reproduction is unexpectedly
similar to the increase in lipid to storage. It supports
the notion that vitellogenin RNAi primarily shifts
lipid investment, and only slightly reduces the abso-
lute amount of lipid in the two organs (i.e., the
ovary and the fat body).
An advantage of physiological manipulation via
RNAi, as opposed to classical surgical removal of
endocrine organs, is that endocrine signaling pre-
sumably remains intact upon RNAi. However, the
possibility remains that knocking down a transcript
via RNAi secondarily affects signaling of a hormone
involved in related processes. To begin to address
this, we measured ecdysteroids in the hemolymph.
Ecdysteroids are not directly involved in vitellogene-
sis in lubber grasshoppers. They are produced by the
ovary (ecdysteroids are absent from ovariectomized
females) and found at high levels for an approxi-
mately 4-day period about 2 weeks before oviposi-
tion (Hatle et al. 2003b). Hence, the presence of
ecdysteroids can indicate whether the ovary is still
functioning as an endocrine organ and also can in-
dicate the timing of its development. Surprisingly,
upon RNAi against vitellogenin, hemolymph ecdys-
teroids were not significantly different from ecdyster-
oids upon RNAi against Hex-90 or injection of
buffer. Although levels of ecdysteroids observed in
these animals were low and warrant retesting, the
present data suggest that RNAi halting of ovarian
growth does not affect ovarian development as an
endocrine organ.
The protein and lipid results of our vitellogenin
RNAi treatment are similar to ovariectomy in young
grasshoppers (Hatle et al. 2008, 2013). Upon ovari-
ectomy, vitellogenin continues to be produced by the
fat body but has nowhere to go, so vitellogenin in
the hemolymph accumulates to high levels. By age
40 days (the age of first oviposition in intact indi-
viduals), grasshoppers have levels of total reproduc-
tive proteins (i.e., hemolymph vitellogenin plus
ovarian vitellin) that are similar to intact controls.
Thereafter (i.e., 50–150 days), levels of total repro-
ductive proteins decrease and levels of storage pro-
teins increase (Hatle et al. 2008). We hypothesize
that females treated with vitellogenin RNAi, as they
get older, will decrease reproductive investment,
increase protein storage, and extend lifespan.
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